| |
|
EVENT DETAILS |
In partnership with Women in Bio, BioPathways throughout 2021, will feature prominent female biotech founders, executives, & VCs.
About this event
Featuring Lindsay Androski, Founder, President & CEO of Roivant Social Ventures
Lindsay Androski is the founder, President & CEO of Roivant Social Ventures, a social impact organization that makes early stage investments & incubates biotechs focused on improving healthcare access & outcomes for underserved groups. Ms. Androski currently serves as President of Incubate, an advocacy organization that educates policymakers on the critical role of early-stage venture capital in biopharma. She is also a member of the MIT board of trustees & sits on the MIT Visiting Committees for Sponsored Research, the Department of Biology, & the Department of Humanities.
A noted expert in the creation, launch & scaling of biotechs, Ms. Androski joined the founding team at Roivant Sciences to build & lead the team responsible for the in-license or acquisition of more than 30 pharmaceutical drug candidates, resulting in the launch of 16 biotechs, three of which went public. To date, these efforts have led to four approved drugs now available to patients: Myfembree (heavy menstrual bleeding / uterine fibroids), Orgovyx (prostate cancer), Gemtesa (overactive bladder), & Rethymic (pediatric congenital athymia). In addition to her dealwork, Ms. Androski led hiring of CEOs & CMO's, partnership efforts in Japan & China, alliance management across the Roivant family of companies, & the intellectual property team.
Ms. Androski previously joined the Department of Justice as one of the inaugural Assistant U.S. Attorneys in the newly-launched Cybercrime unit of the Eastern District of Virginia. As a federal prosecutor, Ms. Androski was involved in investigations & prosecutions of high-profile cybercrime & national security cases, including WikiLeaks/Assange/Manning, Edward Snowden, & MegaUpload/Kim Dotcom, was nominated several times for the highest award given by the Department of Justice, & received the highest awards given by Immigration & Customs Enforcement & Customs & Border Protection. She then took that expertise back to the private sector, launching & leading the Cyber & Data Security practice group at Irell & Manella LLP. She is admitted to practice law in the U.S. Supreme Court, the U.S. Courts of Appeals for the Federal & Fourth Circuits, & the courts of California, New York, & the District of Columbia.
Ms. Androski holds two BS degrees from the Massachusetts Institute of Technology (Biology & History), JD & MBA degrees from The University of Chicago, is a registered patent lawyer & a Chartered Financial Analyst. Her writings have been published in Nature Gene Therapy, the Harvard Journal of Law & Public Policy, the John Marshall Review of Intellectual Property Law, & the University of Chicago Legal Forum.
BioPathways is a monthly event series, featuring prominent bioentrepreneurs, biotech executives, & biotech investors in a fireside chat.
|
|
|
|
|
|
